STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more

AI Summary

The FDA approved Trutakna, a kidney disease drug by Vera Therapeutics, to treat IgA nephropathy, marking a significant development in kidney disease treatment in the U.S.

The FDA approved a kidney disease drug from Vera Therapeutics called Trutakna, to treat IgA nephropathy